We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




2013 Online Pathology Progress Test Now Available

By LabMedica International staff writers
Posted on 17 Dec 2013
Print article
The 2013 version of the main exam for progress monitoring and for evaluating and establishing training standards in pathology across Europe is now available.

As of November 25, the 2013 EUROPALS annual pathology test is now available, offered by the European Society of Pathology (ESP) in close collaboration with the European Association of Pathology Chairs & Program Directors (EAPCP). The 2013 test coordinator is Prof. Dr. Fred T. Bosman. It is especially intended for trainees but all ESP member pathologists are free to participate.

The test consists of 100 questions, partly straight, multiple choice questions, partly still-image based and partly virtual-slide based, and extended matching questions. The chosen level is that of a trainee at the end of a residency program. The test comprises of questions with a purely diagnostic orientation, molecular pathology test items, and mechanism of disease-oriented questions.

The test is preferably to be done in one run but can be done in parts if needed. It generally takes approximately 2–2.5 hours in total. A score result will be provided to the test-taker immediately upon completion of the exam. The test is formative—a tool for self-assessment. The results are kept anonymous.

The exam can be taken by logging on to the online (please see Related Links below) with one’s own password; for those without a password, one can be obtained on the website. All existing users are requested to update their Year of Training and Country from “My Account -> Your Details” once logged into PathXL.

Please note prior to taking the test that it is highly recommended to upgrade to the latest versions of Internet Explorer (v9 or v10), Firefox (v24), Google Chrome (v30) or Safari (v5.1.7) for optimal performance and experience. Problems may be experienced using unsupported browsers, such as older versions of Internet Explorer. Tablets or mobile devices are not supported for the test.

Related Links:

European Society of Pathology
Pathxl
EUROPALS Annual Pathology Test


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.